Gentium names CEO, closes NY office

Following it's license agreement with Sigma-Tau, Gentium said it will be closing its New York office and consolidating corporate activities and the executive management team within its headquarters in Italy. CFO Gary Gemignani will be leaving the company at the end of the month, and Dr. Khalid Islam, currently Gentium's Chairman and Interim CEO, will become the full-time CEO. Gentium release

Suggested Articles

A phase 1/2b test showed Roche's antibody mosunetuzumab can trigger durable responses in a significant minority of hard-to-treat NHL patients.

Janssen’s BCMA-targeting CAR-T therapy eliminated tumors in 69% of patients with advanced multiple myeloma in a small phase 1 study.

In a study, BMS' CAR-T therapy banished tumors in more than half and shrank tumors in nearly three-quarters of relapsed blood cancer patients.